These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 19155619

  • 1. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
    Cremades R, Santos A, Rodríguez JC, García-Pachón E, Ruiz M, Escribano I, Royo G.
    Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
    [Abstract] [Full Text] [Related]

  • 2. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK, Garg P, Babu KH, Gopinathan U, Sharma S.
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [Abstract] [Full Text] [Related]

  • 3. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J, García-Agudo L, Flores S, Rodríguez MJ, Marín P, García-Martos P.
    Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
    [Abstract] [Full Text] [Related]

  • 4. Activities of linezolid against rapidly growing mycobacteria.
    Wallace RJ, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
    [Abstract] [Full Text] [Related]

  • 5. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 6. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R, Cockrum P, Crider J, Schlech B.
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [Abstract] [Full Text] [Related]

  • 7. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH.
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [Abstract] [Full Text] [Related]

  • 8. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
    Cremades R, Santos A, Rodríguez JC, Garcia-Pachon E, Ruiz M, Royo G.
    J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibiotic susceptibility pattern of rapidly growing mycobacteria.
    Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN.
    J Postgrad Med; 2010 Jun; 56(2):76-8. PubMed ID: 20622384
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current treatment of atypical mycobacteriosis.
    Esteban J, Ortiz-Pérez A.
    Expert Opin Pharmacother; 2009 Dec; 10(17):2787-99. PubMed ID: 19929702
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activity of various drugs alone or in combination against Mycobacterium fortuitum.
    Santos A, Cremades R, Rodríguez JC, Garcia-Pachon E, Ruiz M, Royo G.
    J Infect Chemother; 2010 Feb; 16(1):64-7. PubMed ID: 20063030
    [Abstract] [Full Text] [Related]

  • 18. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
    Shen GH, Wu BD, Wu KM, Chen JH.
    Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
    [Abstract] [Full Text] [Related]

  • 19. Activities of Linezolid against nontuberculous mycobacteria.
    Cavusoglu C, Soyler I, Akinci P.
    New Microbiol; 2007 Oct; 30(4):411-4. PubMed ID: 18080676
    [Abstract] [Full Text] [Related]

  • 20. Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin.
    Ortíz-Pérez A, Martín-de-Hijas N, Alonso-Rodríguez N, Molina-Manso D, Fernández-Roblas R, Esteban J.
    Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):79-84. PubMed ID: 21333405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.